NEW: No-Cost StreetSmart Live! Events. This type of intellectual capital is usually not made available to the general public. Learn More

Sector Expert: Philippa Gardner

Edison Investment Research



Recent Quotes

"THLD's TH-302 for glioblastoma could be eligible for accelerated development."

— Philippa Gardner, Edison Investment Research (11/18/14)
more >

"THLD's Phase 3 soft tissue sarcoma trial is to continue as planned."

— Philippa Gardner, Edison Investment Research (9/24/14)
more >

"THLD has initiated a large Phase 2 trial investigating TH-302."

— Philippa Gardner, Edison Investment Research (7/14/14)
more >

"THLD's enterprise value of only about $173M seems undemanding."

— Philippa Gardner, Edison Investment Research (6/11/14)
more >

"Data from two of THLD's Phase 1/2 trials will be presented at ASCO."

— Philippa Gardner, Edison Investment Research (5/23/14)
more >



Due to permission requirements, not all quotes are shown.